Apollo Hospitals Enterprise Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹7,615 Cr +23% YoYSee revenue, profit and what management said. You are viewing Q2 FY26.
AH

Apollo Hospitals Enterprise Ltd

Q2 FY26Healthcare Services

Apollo Hospitals Enterprise Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹6,189Cr
+10.7% YoY
+5.9% QoQ
Net profit
₹494Cr
+24.7% YoY
+12% QoQ
Margin
15%
0 pp YoY
0 pp QoQ
Price₹8,693
Market cap₹1.3L Cr
P/E61.0

The short version

Healthcare Services revenue is expected to grow at 13% organically in existing beds over the next 2-3 years, with an additional 5% growth anticipated from new bed additions in the next two years. Base hospital network margins were around INR 10-15 crore costs built into Q2 FY26, equating to roughly 50 basis points of revenue, with margins already above 25% excluding new beds.

From Apollo Hospitals Enterprise Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Healthcare Services revenue is expected to grow at 13% organically in existing beds over the next 2-3 years, with an additional 5% growth anticipated from new bed additions in the next two years. (Page 13)
  • Apollo HealthCo's revenues grew 18% YoY, supported by an 18% growth in AHLL, indicating strong growth momentum. (Page 3)
  • Digital business GMV (Gross Merchandise Value) growth is targeted between 25%-30% overall, with pharmacy business growing at ~30% YoY and quarter-on-quarter growth of around 5%-7%. Insurance and diagnostics businesses are also set to pick up from Q4 onwards. (Page 6)
  • New hospitals additions: Six new hospitals are planned with phased commissioning from Q3 FY26 to Q1 FY27, expected to contribute to revenue growth. (Page 3)

2 more points from Apollo Hospitals Enterprise Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Apollo Hospitals Enterprise Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Six new hospitals are planned to be added between FY26 and FY27, with Pune and Defense Colony hospitals already soft commissioned in Q3 FY26.
  • Sarjapur Bangalore and Calcutta hospitals are expected to start in Q4 FY26.
  • Hyderabad and Gurugram hospitals anticipated around Q1 FY27 with enhanced facilities including comprehensive oncology programs.
  • Brownfield expansions underway at Jubilee Hills and Secunderabad.
  • Investment in new technologies and clinical programs, including AI interventions in oncology, radiology, and stroke care.
  • Continued expansion of Apollo 24/7 digital platform and related capabilities.

2 more points from Apollo Hospitals Enterprise Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Apollo Hospitals Enterprise Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Apollo Hospitals Enterprise Ltd said on order book & pipeline — free account, 30 seconds.

Apollo Hospitals Enterprise Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Apollo Hospitals Enterprise Ltd Q2 FY26 results — key figures

Apollo Hospitals Enterprise Ltd Q2 FY26 reported results vs Q2 FY25, ₹ crore
₹ CrQ2 FY26Q2 FY25YoYQ1 FY26QoQ
Revenue6,1895,589+10.7%5,842+5.9%
Operating profit (EBITDA)924816+13.2%852+8.5%
Operating margin15%15%0 pp15%0 pp
Profit before tax675557+21.2%583+15.8%
Net profit (PAT)494396+24.7%441+12%
EPS (₹)33.1926.34+26%30.10+10.3%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹7.6K Cr, net profit ₹660 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Maitreya Medicare (Q2 FY26)

    23.92 crore (Page 26). Key investor presentation takeaways from Maitreya Medicare's Q2 FY26 investor presentation — and how it ranks against sector peers.

  • Metropolis Healt (Q2 FY26)

    Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…

  • 3B Blackbio (Q2 FY26)

    Q2 FY 2025-26 sales: ₹3042.83 Lakh (including COVID sales ₹10.23 Lakh), up from ₹2457.55 Lakh in Q2 FY 2024-25. Key concall takeaways from 3B Blackbio DX Ltd's…

  • Unihealth Hosp (Q2 FY26)

    Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India). Key concall takeaways from Unihealth Hospitals Ltd's Q2 FY26…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Apollo Hospitals Enterprise Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Apollo Hospitals Enterprise Ltd Q2 FY26 results?

Healthcare Services revenue is expected to grow at 13% organically in existing beds over the next 2-3 years, with an additional 5% growth anticipated from new bed additions in the next two years. Base hospital network margins were around INR 10-15 crore costs built into Q2 FY26, equating to roughly 50 basis points of revenue, with margins already above 25% excluding new beds.

What is Apollo Hospitals Enterprise Ltd share price analysis?

Apollo Hospitals Enterprise Ltd currently shows a neutral. The stock trades at a P/E of 61.0 with a market cap of ₹128,263 Cr. Investors should review the full earnings analysis for detailed insights.

Is Apollo Hospitals Enterprise Ltd planning capital expenditure?

Six new hospitals are planned to be added between FY26 and FY27, with Pune and Defense Colony hospitals already soft commissioned in Q3 FY26.

Keep Apollo Hospitals Enterprise Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.